Kreis NN - Search Results

1

p53 is not directly relevant to the response of Polo-like kinase 1 inhibitors.

Sanhaji M, Kreis NN, Zimmer B, Berg T, Louwen F, Yuan J. Sanhaji M, et al. Among authors: kreis nn. Cell Cycle. 2012 Feb 1;11(3):543-53. doi: 10.4161/cc.11.3.19076. Epub 2012 Feb 1. Cell Cycle. 2012. PMID: 22262171

2

Long-term downregulation of Polo-like kinase 1 increases the cyclin-dependent kinase inhibitor p21(WAF1/CIP1).

Kreis NN, Sommer K, Sanhaji M, Krämer A, Matthess Y, Kaufmann M, Strebhardt K, Yuan J. Kreis NN, et al. Cell Cycle. 2009 Feb 1;8(3):460-72. doi: 10.4161/cc.8.3.7651. Epub 2009 Feb 18. Cell Cycle. 2009. PMID: 19177004

3

Functional and spatial regulation of mitotic centromere-associated kinesin by cyclin-dependent kinase 1.

Sanhaji M, Friel CT, Kreis NN, Krämer A, Martin C, Howard J, Strebhardt K, Yuan J. Sanhaji M, et al. Among authors: kreis nn. Mol Cell Biol. 2010 Jun;30(11):2594-607. doi: 10.1128/MCB.00098-10. Epub 2010 Apr 5. Mol Cell Biol. 2010. PMID: 20368358 Free PMC article.

4

Polo-box domain inhibitor poloxin activates the spindle assembly checkpoint and inhibits tumor growth in vivo.

Yuan J, Sanhaji M, Krämer A, Reindl W, Hofmann M, Kreis NN, Zimmer B, Berg T, Strebhardt K. Yuan J, et al. Among authors: kreis nn. Am J Pathol. 2011 Oct;179(4):2091-9. doi: 10.1016/j.ajpath.2011.06.031. Epub 2011 Aug 10. Am J Pathol. 2011. PMID: 21839059 Free PMC article.

5

Polo-like kinase 1 inhibitors, mitotic stress and the tumor suppressor p53.

Sanhaji M, Louwen F, Zimmer B, Kreis NN, Roth S, Yuan J. Sanhaji M, et al. Among authors: kreis nn. Cell Cycle. 2013 May 1;12(9):1340-51. doi: 10.4161/cc.24573. Epub 2013 Apr 10. Cell Cycle. 2013. PMID: 23574746 Free PMC article.

6

Function of survivin in trophoblastic cells of the placenta.

Muschol-Steinmetz C, Friemel A, Kreis NN, Reinhard J, Yuan J, Louwen F. Muschol-Steinmetz C, et al. Among authors: kreis nn. PLoS One. 2013 Sep 19;8(9):e73337. doi: 10.1371/journal.pone.0073337. eCollection 2013. PLoS One. 2013. PMID: 24069188 Free PMC article.

7

Loss of p21Cip1/CDKN1A renders cancer cells susceptible to Polo-like kinase 1 inhibition.

Kreis NN, Louwen F, Zimmer B, Yuan J. Kreis NN, et al. Oncotarget. 2015 Mar 30;6(9):6611-26. doi: 10.18632/oncotarget.2844. Oncotarget. 2015. PMID: 25483104 Free PMC article.

8

B-cell lymphoma 6 promotes proliferation and survival of trophoblastic cells.

Muschol-Steinmetz C, Jasmer B, Kreis NN, Steinhäuser K, Ritter A, Rolle U, Yuan J, Louwen F. Muschol-Steinmetz C, et al. Among authors: kreis nn. Cell Cycle. 2016;15(6):827-39. doi: 10.1080/15384101.2016.1149273. Cell Cycle. 2016. PMID: 27029530 Free PMC article.

9

Molecular insight into the regulation and function of MCAK.

Ritter A, Kreis NN, Louwen F, Wordeman L, Yuan J. Ritter A, et al. Among authors: kreis nn. Crit Rev Biochem Mol Biol. 2015 Jul-Aug;51(4):228-45. doi: 10.1080/10409238.2016.1178705. Epub 2016 May 5. Crit Rev Biochem Mol Biol. 2015. PMID: 27146484 Review.

10

Mitotic p21Cip1/CDKN1A is regulated by cyclin-dependent kinase 1 phosphorylation.

Kreis NN, Friemel A, Zimmer B, Roth S, Rieger MA, Rolle U, Louwen F, Yuan J. Kreis NN, et al. Oncotarget. 2016 Aug 2;7(31):50215-50228. doi: 10.18632/oncotarget.10330. Oncotarget. 2016. PMID: 27384476 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

39 results

Search Page